 Analysts expect Denali Therapeutics Inc NASDAQ:DNLI to announce 5.93 million in sales for the current quarter, Zacks reports. Six analysts have provided estimates for Denali Therapeutics earnings. The lowest sales estimate is 4.00 million and the highest is 13.50 million. Denali Therapeutics posted sales of 4.21 million in the same quarter last year, which suggests ... 